Clinical trial

First in Human Study of QLS5316 in Solid Tumors

NCT07358884

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-01-01

PhasePHASE1

Study timeline

Study start (estimated)2026-01-01Date precision: month

Registry last updated2026-01-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Solid Tumorsunresolved

Colorectal Cancerunresolved

Gastric Cancer or Gastroesophageal Junction Adenocarcinomaunresolved

Head and Neck Squamous Cell Carcinomaunresolved

Non-small Cell Lung Cancerunresolved

Interventions

QLS5316DRUG

Sponsors & collaborators

Qilu Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07358884 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.